Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

795 results about "Vaccination" patented technology

Vaccination is the administration of a vaccine to help the immune system develop protection from a disease. Vaccines contain a microorganism or virus in a weakened or killed state, or proteins or toxins from the organism. In stimulating the body's adaptive immunity, they help prevent sickness from an infectious disease. When a sufficiently large percentage of a population has been vaccinated, herd immunity results. The effectiveness of vaccination has been widely studied and verified. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the elimination of diseases such as polio and tetanus from much of the world.

Application of phloretin in preparation of medicine or feed additive for treating or preventing swine envelope virus infection

The invention discloses an application of phloretin in preparation of a medicine or a feed additive for treating or preventing swine envelope virus infection, the medicine is phloretin or oral liquid, granules, tablets and powder prepared from phloretin as an effective component and a solvent or an auxiliary material, and the use dosage is 2.5-10mg / kg of the body weight of a pig; or the phloretin is directly added into the feed, and the addition amount of the phloretin is 0.01-0.03% of the total weight of the pig feed. The phloretin or the composition containing the phloretin is used as a medicine or a feed additive, is high in safety and free of toxic and side effects, and has the effects of remarkably inhibiting replication of envelope viruses such as porcine epidemic diarrhea virus, porcine reproductive and respiratory syndrome virus and African swine fever virus and reducing the toxicity of the porcine envelope viruses; the defects of immune failure possibly caused by vaccination, virus variation caused by use of antiviral drugs and the like are overcome, the morbidity and mortality of the piglets infected with the swine envelope virus are effectively reduced, and the effect of preventing and treating or preventing the swine envelope virus infection diseases is achieved.
Owner:WUHAN POLYTECHNIC UNIVERSITY

Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy

The present invention relates to methods for predicting whether peptides or polypeptides comprising disease specific amino acid modifications, in particular tumor-associated neo-antigens, comprise epitopes, in particular tumor-associated neo-epitopes, which are useful for immunotherapy such as for vaccination. The methods of the invention may be used, in particular, for the provision of vaccines which are specific for a patient's tumor and, thus, in the context of personalized cancer vaccines.
Owner:BIONTECH SE

An AI-driven predictive healthcare system for pandemic prevention

A system for AI-driven predictive healthcare for pandemic prevention, which includes the following: a data collection module configured to capture health-related data from IoT-based wearable devices, electronic health records (EHRs), environmental sensors, and social media in real time; an AI-driven analysis module that is operationally linked to the data collection module and configured to use deep learning and natural language processing (NLP) techniques to process and analyze collected data in order to detect potential disease outbreaks; a predictive modeling module configured to use hybrid epidemiological and AI models to predict disease transmission patterns based on mobility data, population density, and historical infection trends; a warning and response module that automatically generates and disseminates notifications to health authorities, medical professionals, and vulnerable individuals based on predicted outbreak risks; a blockchain-based data security module configured to ensure the secure storage, access control, and verification of health-related data through decentralized ledger technology and smart contracts; and a decision support module that is operationally linked to the predictive modeling module and provides AI-driven recommendations for healthcare resource allocation, vaccination strategies, quarantine measures and public health measures.
Owner:KUMAR PRINCE ALPHARETTA

Pancreatic cancer immunotherapy using cationic lipid and polymer nanocarriers for co-delivery of KRAS neoantigens and sting and / or other immunomodulators to boost the cancer immunity cycle and treat liver metastasis

Drug delivery nanoparticle compositions and methods for the treatment of a cancer are provided that can be used individually or in combination. These compositions and methods include: (1) exogenous vaccination using neoantigens or tumor-associated antigens to potentiate an anti-tumor immune response; (2) nanoparticle-based drug delivery targeting the liver, aimed at reprogramming the hepatic immune environment to reduce or eliminate tumor antigen tolerance, thereby enhancing the immune system's ability to combat metastatic cancer; and (3) expansion of the liver metastasis treatment platform to target tumor-associated lymphoid structures, supporting the immune response at the primary tumor site. Any of these methods may be optionally combined with chemo-immunotherapy for enhanced efficacy.
Owner:RGT UNIV OF CALIFORNIA

Lentinus edodes liquid strain inoculation device

The utility model belongs to the technical field of lentinus edodes liquid strain inoculation, and particularly relates to a lentinus edodes liquid strain inoculation device which comprises a base, a containing base used for containing a fungus bag is fixed to the top of the base, two first air cylinders are symmetrically fixed to the top of the base, and L-shaped baffles are fixed to the ejection ends of the first air cylinders. The L-shaped baffle is slidably connected to the top of the base, a vertical plate is fixed to the top of the base, and a fixing plate is fixed to the front face of the vertical plate. Through the arrangement of the placing seat, the first air cylinder and the L-shaped baffle plate, the mushroom bag can be more conveniently stabilized, through the arrangement of the vertical plate, the fixed plate, the second air cylinder, the mounting plate, the multi-branch inoculation pipe, the storage box, the water pump, the liquid pumping pipe and the liquid feeding hose, the mushroom liquid strain can be more conveniently and quickly inoculated on the mushroom bag, and through the arrangement of the stirring assembly, the mushroom liquid strain can be more conveniently and quickly inoculated. The mushroom liquid strain inoculation device is simple in structure, capable of preventing the mushroom liquid strain from precipitating, good in overall using effect, time-saving and labor-saving in operation and high in inoculation efficiency.
Owner:HENAN HUANQI AGRICULTURAL DEVELOPMENT CO LTD

Preparation method and application of larimichthys crocea iridovirus disease recombinant live vector vaccine

The invention relates to the field of aquaculture, in particular to a preparation method and application of a larimichthys crocea iridovirus recombinant live vector vaccine. According to the invention, replication-deficient type 5 adenovirus is selected as a target gene expression vector, a recombinant adenovirus vector comprising main capsid protein of iridovirus is constructed, recombinant virus is obtained, and the safe and effective large yellow croaker iridovirus disease recombinant live vector vaccine is created. According to the vaccine, the larimichthys crocea is immunized in a soaking or bait feeding mode, the CPM of the larimichthys crocea immunized by the vaccine is 12.0%, and the CPM of the fish without being immunized by the vaccine is 62.0%. In addition, the RPS of the inoculated fish and the RPS of the empty carrier control group fish are 80.65% and 9.68% respectively. The method is at a leading level in the field of pseudosciaena crocea biomedicine at present, and creativity is remarkable.
Owner:EAST CHINA SEA FISHERIES RES INST CHINESE ACAD OF FISHERY SCI

Preparation method of polylactic acid porous microspheres and application of polylactic acid porous microspheres in stem cell inoculation

The invention relates to the technical field of functional composite materials, and discloses a preparation method of polylactic acid porous microspheres and application of the polylactic acid porous microspheres in stem cell inoculation, and the preparation method comprises the following steps: (1) dissolving chitosan in an acetic acid aqueous solution, adding bioactive glass nanoparticles, and performing ultrasonic treatment to obtain an aqueous phase solution; (2) dissolving PLGA or PLA in dichloromethane, and adding an emulsifier to obtain an oil phase solution; (3) dropwise adding the water-phase solution into the oil-phase solution to obtain a water-in-oil primary emulsion; (4) dropwise adding the water-in-oil primary emulsion into a PVA aqueous solution to obtain a double emulsion; and (5) stirring the double emulsions, carrying out centrifugal separation, drying, and immersing in a glutaraldehyde solution for cross-linking treatment to obtain the porous microspheres. The porous microspheres are prepared by a double-emulsion solvent evaporation method, and have more uniform pore size distribution and higher biological activity, so that the porous microspheres can be used as an excellent stem cell inoculation carrier to meet the attachment and proliferation of high-proportion cells.
Owner:ZHEJIANG CANWELL MEDICAL DEVICES CO LTD

Enhancing the effect of CAR-engineered T cells by means of nucleic acid vaccination

The present invention generally embraces the treatment of diseases by targeting cells expressing an antigen on the cell surface. In particular the invention relates to a method for stimulating, priming and / or expanding in vivo T cells genetically modified to express a chimeric antigen receptor (CAR) targeted to an antigen, comprising contacting the T cells with the antigen or a variant thereof in vivo. In one embodiment, the antigen or variant thereof is provided by administering a nucleic acid encoding the antigen or variant thereof.
Owner:TRON TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIV MAINZ GEMEINNUETZIGE GMBH +1

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

The invention provides a method for obtaining a broadly neutralizing antibody (bNab), including screening memory B cell cultures from a donor PBMC sample for neutralization activity against a plurality of HIV-1 species, cloning a memory B cell that exhibits broad neutralization activity; and rescuing a monoclonal antibody from that memory B cell culture. The resultant monoclonal antibodies may be characterized by their ability to selectively bind epitopes from the Env proteins in native or monomeric form, as well as to inhibit infection of HIV-1 species from a plurality of clades. Compositions containing human monoclonal anti-HIV antibodies used for prophylaxis, diagnosis and treatment of HIV infection are provided. Methods for generating such antibodies by immunization using epitopes from conserved regions within the variable loops of gp120 are provided. Immunogens for generating anti-HIV1 bNAbs are also provided. Furthermore, methods for vaccination using suitable epitopes are provided.
Owner:THE SCRIPPS RES INST +2

Application of kaempferol in preparation of medicine for treating or preventing porcine epidemic diarrhea virus infection

The invention discloses an application of kaempferol in preparation of a medicine for treating or preventing PEDV (Porcine Epidemic Diarrhea Virus) infection. The kaempferol can obviously inhibit the replication of the PEDV in Vero and LLC-PK1 cells through 3C-like protease targeting the PEDV, so that the kaempferol can be used for preparing the medicine for preventing and treating the PEDV. Besides, kaempferol, as a natural substance separated from mulberries, can be used as a feed additive for a long time so as to achieve the purpose of preventing epidemic diseases, and does not cause generation of drug-resistant strains and other toxic and side effects after being used for a long time; the defects of immune failure possibly caused by vaccination, virus variation caused by use of antiviral drugs and the like are overcome.
Owner:WUHAN POLYTECHNIC UNIVERSITY

Antigen fusion protein and application thereof in preparation of live vaccine for preventing infectious bursal disease

The invention discloses an antigen fusion protein and application thereof in preparation of a live vaccine for preventing infectious bursal disease. Specifically disclosed are antigen fusion proteins comprising a VP2 protein, a trimer tag, and a C3d protein. The invention also discloses recombinant Eimeria heap constructed by using the antigen fusion protein and application of the recombinant Eimeria heap in preparation of IBDV live vaccines. The oocyst of the recombinant Eimeria heap can effectively induce humoral immune response aiming at IBDV as a vaccine active ingredient, the level of an induced antibody is obviously higher than that of an insect strain expressed by a single VP2 antigen, viruses can be more effectively neutralized, the immune protection efficacy is improved, the safety is high, and the oocyst has the potential of serving as a live vector genetic engineering vaccine. The IBDV live vaccine can be orally taken through drinking water or feed, vaccination is simple, large-scale immunization of chicken flocks can be achieved, and the IBDV live vaccine is economical and efficient and has a wide prospect of being applied to prevention and control of the IBDV of the chicken flocks.
Owner:CHINA AGRI UNIV

Inoculation table capable of alternately receiving medicines

The utility model discloses an inoculation table capable of alternately receiving medicines, belongs to the technical field of vaccine distribution automation, and solves the problem of low seedling emergence efficiency of the inoculation table capable of alternately receiving medicines in the prior art. The inoculation table capable of alternately receiving the medicines comprises an electric drawer, a vaccine guide device, a guide switching device, an AGV (Automatic Guided Vehicle) distribution vehicle and a vaccine pouring device, the at least two electric drawers are vertically arranged, the guide switching device can adjust the position of the vaccine guide device so that vaccines can alternately enter the two electric drawers, and the AGV distribution vehicle is used for providing power for movement of the guide switching device and the vaccine pouring device. According to the vaccination table capable of alternately receiving the medicines, vaccines can be alternately put into the two electric drawers through the arrangement of the AGV distribution vehicle, the vaccine pouring device, the guide switching device and the vaccine guide device, and the electric drawers are vertically arranged; two drawers for alternately receiving vaccines can be vertically arranged on one inoculation station, and the comfort level of medical staff is not affected.
Owner:SHEN SU AUTOMATION TECH DEV CO LTD

An Immunogenic Composition of Disease-Associated Antigens for Use in a Vaccine, Antibody Production and Immunodiagnostic Tests

The invention is based on the deletion of 21 amino acids from the C-terminal region of the S2 subunit of SARS-CoV2-S protein and transporting the Si subunit, which is fused to S2 to the cell membranes. In this way, the presentation of the antigenic S1 subunit of SARS-CoV2-S protein in large amounts and in its natural structure in the cell membrane and its use as a whole cell or cell membrane has been determined as a new vaccination protocol for the SARS-CoV-2. Designing the S2 subunit of SARS-CoV2-S protein as a carrier, fusing any bacterial, viral, and tumor proteins with antigenic properties and transporting it to the cell membrane will be a comprehensive vaccination protocol that will cover all bacteria, viruses and even tumors.
Owner:SAHIN FIKRET

Systems and methods to generate b cells genetically modified to express selected antibodies

The present application relates to systems and methods to generate B cells genetically modified to express selected antibodies. The systems and methods can be used to: eliminate the need for classical vaccination; providing protection against infections available for current vaccination; providing protection against infections when the patient is additionally subjected to immunosuppression; and / or provides benefits provided by therapeutic antibodies, such as in the treatment of autoimmune disorders.
Owner:弗莱德哈钦森癌症中心

Two-component platform for trans amplifying RNA (TARNA) vaccination

This disclosure provides, in some aspects, multi-component trans-amplifying RNA (taRNA) vaccines that comprise a first nanoparticle (R-NP) comprising a polynucleotide encoding a replicase and a second nanoparticle (Tr-NP) comprising a polynucleotide comprising a nucleic acid encoding a payload (e.g., antigen), operably linked to a conserved sequence element (CSE) that is cognate to the replicase; methods of production thereof; and methods of use thereof.
Owner:AMPLITUDE THERAPEUTICS INC

Channel type plateau grazing yak epidemic prevention sampling mating fence

The utility model belongs to the technical field of breeding fences, and provides a channel type plateau grazing yak epidemic prevention sampling mating fence which comprises a fence body, a first connecting rod and a second connecting rod. A plurality of first supporting rods and second supporting rods are fixedly connected to the bottom surfaces of the two sets of top rods, a plurality of connecting rods are installed between the two sets of top rods in an array mode, cells are formed between the first supporting rods and the second supporting rods, and surrounding rods are installed in the cells in an array mode; the first door body is fixed at the inlet end of the fence body; the second door body is fixed at the outlet end of the fence body; by arranging the fence body, the first door body and the second door body, the operation efficiency of vaccination, sampling and hybridization is greatly improved, and the current situation that an existing fence is small in yak processing number and low in efficiency is changed.
Owner:新疆生产建设兵团第十二师畜牧兽医工作站

Animal vaccination risk prediction method and system based on cross-modal large model

The invention provides an animal vaccination risk prediction method and system based on a cross-modal large model, and relates to the technical field of vaccination risk prediction. Comprising a multi-modal data acquisition and integration module, a cross-modal feature extraction and semantic alignment module, a pre-training model construction and transfer learning module, a risk prediction and decision support module and a model verification and iterative optimization module. Misjudgment caused by same surface symptoms can be effectively avoided, in animal epidemic disease diagnosis, similar symptoms may be caused by different viruses, a traditional method is easily interfered by surface phenomena, and the optimized method can be used for diagnosis of animal epidemic diseases by constructing a causal diagram, analyzing real causes of symptoms and stripping confounding factors such as environment and physiological status. Through the means, the model can more accurately distinguish virus types, the misjudgment risk is remarkably reduced, and a reliable basis is provided for a subsequent vaccination strategy.
Owner:潘海澄

Poultry vaccination marking mechanism

The utility model discloses a poultry vaccination marking mechanism which comprises an ink jet mechanism, the ink jet mechanism is flat and hollow and is connected with an external liquid pump through a hose, one side of the ink jet mechanism is provided with a nozzle, the other side of the ink jet mechanism is rotatably provided with a limiting ball, one end of the limiting ball is connected with a connecting mechanism through a connecting rod, and the other end of the limiting ball is connected with the connecting mechanism. The input end of the liquid pump is connected with an ink box containing marking ink through a pipeline, and the output end of the liquid pump is connected with the ink jetting mechanism through a hose. The trigger switch of the liquid pump can be linked with the vaccine injector, when the vaccine injector is started to inject vaccines once, the liquid pump operates once, a certain amount of ink is sprayed to feathers on poultry bodies, and the ink-jet mechanism is linked with the vaccine injection mechanism to inject the vaccines into the feathers. Meanwhile, the poultry feather marking device is small and exquisite in design, light, simple in structure, low in use and maintenance cost and suitable for small-scale poultry breeding.
Owner:JIANGXI XINJISEN POULTRY IND CO LTD

Compositions and methods for enhancement of mRNA vaccine performance and vaccination against mpox

The current disclosure includes a modular vaccine platform. Also included are monkeypox vaccines that protect against pathogenic monkeypox species, as well as their variants. The vaccines typically include a modified mRNA encoding at least one immunogen, such as a viral envelope protein, cell surface binding protein, or a biologically effective / significant fragment thereof. The mRNA can be encapsulated into lipid nanoparticles or other carriers and formulated as pharmaceutical compositions that can be used to generate an immune response to pathogens, including monkeypox virus, in a subject.
Owner:YALE UNIVERSITY

Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease

The present invention provides methods and compositions for the stimulation of immune responses and for treating or preventing allergic disease and responses and inflammatory disease and responses. In particular, the present invention provides nanoemulsion compositions and methods of using the same for the induction of immune responses that prevent or treat allergic disease by reducing allergic response. Compositions and methods of the invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
Owner:THE RGT UNIV OF MICHIGAN

Crowd antibody concentration dynamic evaluation method based on neural network simulation calculation

The invention discloses a population antibody concentration dynamic evaluation method based on neural network simulation calculation. The method comprises the following steps: S1, acquiring a multi-modal immunology related data set; s2, generating a complete multi-modal feature data set; s3, constructing a deep learning model based on the multi-modal feature data set; s4, training the segmented neural network model; s5, inputting the multi-modal immunology related data of the to-be-evaluated crowd into the trained sectional neural network model, and generating a prediction result of the individual antibody concentration changing along with time; s6, summarizing prediction data of a plurality of individuals according to the prediction result of the individual antibody concentration changing along with time, and establishing a population overall antibody concentration dynamic distribution model; and S7, providing vaccination optimization strategy suggestions and crowd immune intervention schemes in combination with data output. The invention provides key technical support for immune monitoring and vaccination strategy optimization.
Owner:BEIJING UNITED JINWEI INFORMATION TECHNOLOGY CO LTD

Antisense long noncoding RNAS for the modification of gene expression and for therapeutic applications

PCT designated stage expiredWO2025011876A2DNA/RNA fragmentationVaccinationgenomic DNA
The present invention relates to an antisense long non-encoding RNA (aslncRNA) that may form a partial double stranded (ds) complex with a corresponding cellular mRNA in eukaryotic cells and to a biological complex comprising the antisense lncRNA and a target mRNA that may together form a partial double stranded complex in vitro. The dsRNA complex is preferentially exported from the nucleus and translated in the cytoplasm and thereby gene expression is boosted. In addition to boosting aslnc-RNAs inhibitiory aslnc RNAs are disclosed. An expression vector comprising a nucleic acid sequence of the aslncRNA is also disclosed. The present invention can be used to increase or decrease export of a target mRNA from the nucleus and thus, to increase or decrease gene expression without interfering with genomic DNA or with mRNA levels. Methods to increase or decrease the export and / or expression of a target mRNA, cell transfections using plasmids expressing the antisense lncRNA or using conjugates comprising the aslncRNA, and a pharmaceutical composition comprising the as-lncRNA are also disclosed. The aslncRNA, the complex, the expression vector, and the conjugate are useful for enhancing the production of recombinant proteins that are used in biotechnological applications and for medical purposes. The aslncRNA is also useful for increasing antigen presentation upon mRNA vaccination.
Owner:GEORG AUGUST UNIVERSITAT GOTTINGEN STIFTUNG OFFENLICHEN RECHTS

VLP immunotherapy combined with ablation

Provided herein is a novel, multimodal in situ vaccination approach to treat cancer by combining ablation with administration of the naturally occurring plant virus or virus-like particle (VLP) nanoparticles such as cowpea mosaic virus (CPMV), a plant virus-based immunoadjuvant.
Owner:RGT UNIV OF CALIFORNIA

Vaccine syringe for Tibetan pig disease prevention and treatment

ActiveCN223403978UAnimal fetteringTibetan pigDisease
The utility model belongs to the technical field of Tibetan pig disease prevention and treatment, particularly relates to a vaccine injector for Tibetan pig disease prevention and treatment, and aims to solve the problems that when vaccine injection is carried out on Tibetan pigs in the same batch of growth stage, workers often hold injectors with hands to go to pigsties to inject the Tibetan pigs one by one, piglets missing vaccine injection are prone to occurring, and potential risks exist. According to the scheme, the device comprises an electric conveying belt, the electric conveying belt is arranged on a channel between two adjacent pigsties, and two guardrails for preventing piglets from falling off are symmetrically arranged above the electric conveying belt. When the piglet vaccine injection device is used, through the design of the electric conveying belt and the guardrails, a worker can conveniently inject vaccines to piglets one by one, and therefore the situation that the piglets are missed to be vaccinated is avoided; through the design of the adjusting assembly, the distance between the guardrails can be adjusted according to the body types of piglets of different growth batches; through the design of the needle-free injection assembly, stress reaction and cross infection risks caused by traditional needle puncture are avoided.
Owner:乡城县动物疫病预防控制中心

Compositions, kits, and methods for duplex immunoassay for Anti-SARS-COV-2 antibodies

Kits containing a multiplexed chemiluminescent detection system and microfluidics devices and methods for detecting the presence and / or concentration of anti-SARS-CoV-2 antibodies in a sample are disclosed. The kits, microfluidics devices, and methods utilize singlet oxygen-activatable chemiluminescent compounds in combination with two or more fluorescent molecules that emit light at different wavelengths. In certain non-limiting embodiments, the kits, microfluidics devices, and methods can distinguish between anti-SARS-CoV-2 antibodies generated in response to vaccination from anti-SARS-CoV-2 antibodies generated in response to infection.
Owner:SIEMENS HEALTHCARE DIAGNOSTICS INC

Stabilized lipid and lipidoid nanoparticle formulations with specific surfactant properties for enhanced pharmaceutical applications

This invention presents novel lipid and lipidoid nanoparticle (LNP and LiNP) formulations enhanced with specifically characterized surfactants. These surfactants exhibit unique Langmuir isotherm properties, ensuring optimal stabilization of the nanoparticles. The described formulations improve the stability, reduce aggregation, and mitigate challenges faced during purification, such as filtration clogging or fouling. Integral to the innovation is a method for determining the suitability of surfactants as stabilizers based on predetermined Langmuir isotherm values and filtration speeds. The stabilized nanoparticles, when formulated with therapeutic agents, have demonstrated potential in medical applications, particularly in the realm of mRNA delivery, vaccination and immunization.
Owner:ETHRIS

Tumor nano vaccine of bionic autophagosome as well as preparation method and application of tumor nano vaccine

The invention discloses a tumor nano vaccine (BAPs) of bionic autophagosome as well as a preparation method and application thereof, and the vaccine effectively stimulates anti-tumor immunity by precisely fusing a neoantigen derived from the autophagosome and an immunologic adjuvant targeted lymph node. The BAPs with the redox response characteristic promote the vaccine to be opened in antigen presenting cells, so that an adjuvant and an antigen are exposed, and a strong immune response is stimulated. The BAPs can excite wide T cell reactions, and finally, more than 70% of established tumors are effectively eliminated. BAPs vaccination initiates a lasting T cell reaction and provides powerful protection, all mice are protected in tumor recurrence challenge, and the tumor incidence rate is significantly reduced by nearly 90%. In addition, the BAPs and a checkpoint inhibition therapy have a synergistic effect, and growth of breast cancer with poor immunogenicity is inhibited. The BAPs nano vaccine provides an efficient strategy with clinical transformation potential to enhance the strong immune response of personalized cancer immunotherapy.
Owner:SUZHOU UNIV

Fusion protein and granulated antigen containing same

A fusion protein, and compositions, kits, granulated antigens, vaccines and pharmaceutical compositions comprising the same. The invention also relates to a fusion protein and a composition comprising the fusion protein, a kit and application of the granulated antigen in preparation of a pharmaceutical composition or a vaccine. The granulated antigens are particularly suitable for vaccine production and vaccination and have advantages in the prevention and / or treatment of viral infections.
Owner:XIAMEN UNIV +1